Canada Drug Delivery Devices Market Outlook to 2033 - Central Venous Catheters , Implantable Ports and Infusion Systems

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Drug Delivery Devices Market, Canada, Revenue ($m), 2018-2033
3.2 Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2023
3.3 Drug Delivery Devices Market, Canada, Category Contribution by Revenue ($m), 2023
3.4 Drug Delivery Devices Market, Canada, Revenue ($m), 2018-2033
3.5 Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033
3.6 Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033
3.7 Drug Delivery Devices Market, Canada, Company Share by Revenue ($m), 2023

4.1 Central Venous Catheters Market, Canada, Revenue Mix ($m), 2023
4.2 Central Venous Catheters Market, Canada, Segment Contribution (%), 2023
4.3 Central Venous Catheters Market, Canada, Revenue ($m), 2018-2033
4.4 Central Venous Catheters Market, Canada, Volume (Units), 2018-2033
4.5 Central Venous Catheters Market, Canada, Average Price ($) , 2018-2033
4.6 Central Venous Catheters Market, Canada, Distribution Share by Revenue ($m), 2023
4.7 Central Venous Catheters Market, Canada, Company Share by Revenue ($m), 2023

5.1 Implantable Ports Market, Canada, Revenue Mix ($m), 2023
5.2 Implantable Ports Market, Canada, Segment Contribution (%), 2023
5.3 Implantable Ports Market, Canada, Revenue ($m), 2018-2033
5.4 Implantable Ports Market, Canada, Volume (Units), 2018-2033
5.5 Implantable Ports Market, Canada, Average Price ($) , 2018-2033
5.6 Implantable Ports Market, Canada, Distribution Share by Revenue ($m), 2023
5.7 Implantable Ports Market, Canada, Company Share by Revenue ($m), 2023

6.1 Infusion Systems Market, Canada, Revenue Mix ($m), 2023
6.2 Infusion Systems Market, Canada, Segment Contribution (%), 2023
6.3 Infusion Systems Market, Canada, Revenue ($m), 2018-2033
6.3.1 Infusion Pump Disposables Market, Canada, Revenue ($m), by Segment, 2018-2033
6.3.2 Infusion Pumps Market, Canada, Revenue ($m), by Segment, 2018-2033
6.4 Infusion Systems Market, Canada, Volume (Units), 2018-2033
6.4.1 Infusion Pump Disposables Market, Canada, Volume (Units), by Segment, 2018-2033
6.4.2 Infusion Pumps Market, Canada, Volume (Units), by Segment, 2018-2033
6.5 Infusion Systems Market, Canada, Average Price ($) , 2018-2033
6.6 Infusion Systems Market, Canada, Distribution Share by Revenue ($m), 2023
6.7 Infusion Systems Market, Canada, Company Share by Revenue ($m), 2023

7.1 Becton Dickinson and Co
7.1.1 Company Overview
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.3 Teleflex Inc
7.3.1 Company Overview
7.4 ICU Medical Inc
7.4.1 Company Overview
7.5 Edwards Lifesciences Corp
7.5.1 Company Overview
7.6 Baxter International Inc
7.6.1 Company Overview

9.1 Acquisition
9.1.1 Atai Life Sciences Acquires IntelGenx Technologies and IntelGenx (IGX Entities)
9.2 Debt Offerings
9.2.1 NuGen Medical Devices Raises USD7.33 Million in Private Placement of 12% Secured Convertible Debentures
9.3 Equity Offerings
9.3.1 Stockport Exploration (Sona Nanotech) Raises USD1.21 Million in Non-Brokered Private Placement of Shares
9.3.2 Cypher Metaverse Raises Funds through Final Tranche Non-Brokered Private Placement of Shares
9.3.3 Sona Nanotech Raises USD1.08 Million in Private Placement of Shares
9.3.4 Jolt Health to Raise Upto USD0.36 Million in Non-Brokered Private Placement of Units
9.3.5 Orion Biotechnology Canada Raises USD0.74 Million in Equity Financing
9.3.6 InMed Pharma to Raise Up to USD1.03 Million in Equity Financing

10.1 Corporate Communications
10.1.1 Jan 08, 2025: Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies
10.1.2 Dec 11, 2024: Netramark Expands Team with the Addition of Industry Veteran
10.1.3 Oct 16, 2024: Lobe Sciences Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin
10.1.4 Aug 06, 2024: Valeo Pharma Announces Leadership Changes
10.1.5 Jun 18, 2024: Cannabix Technologies Announces Annual General and Special Meeting Results
10.2 Financial Announcements
10.2.1 Feb 10, 2025: Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
10.2.2 Nov 14, 2024: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information
10.2.3 Sep 09, 2024: Valeo Pharma to Host Third Quarter 2024 Results Conference Call / Webcast
10.2.4 Aug 09, 2024: Elite Pharmaceuticals to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024
10.2.5 Jul 17, 2024: ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
10.2.6 Jun 26, 2024: Elite Pharmaceuticals to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024
10.2.7 Jun 04, 2024: Valeo Pharma to Host Second Quarter 2024 Results Conference Call / Webcast
10.3 Government and Public Interest
10.3.1 Sep 04, 2024: Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
10.3.2 Apr 25, 2024: Cybin to Participate at the 27th Annual Milken Institute Global Conference
10.4 Other Significant Developments
10.4.1 Aug 20, 2024: Netramark Provides Q3 Business Update and Highlights Progress
10.4.2 Jun 25, 2024: Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant
10.4.3 May 17, 2024: Intelgenx Initiates Restructuring Proceedings Under The CCAA To Implement A Review Of Its Strategic Alternatives
10.5 Product News
10.5.1 Apr 15, 2025: Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom
10.5.2 Apr 07, 2025: Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies
10.5.3 Jan 31, 2025: This New Drug Delivery Method Could Offer Long-Lasting Relief for Eye Diseases
10.5.4 Dec 05, 2024: Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania
10.5.5 Dec 02, 2024: BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide
10.5.6 Jul 29, 2024: Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA
10.6 Research And Development
10.6.1 Feb 12, 2025: New Drug Delivery Method Promises Long-Lasting Glaucoma Relief: Study
10.7 Strategy And Business Planning
10.7.1 Mar 19, 2025: Clearmind Medicine Signs Non-binding Letter of Intent With Polyrizon
10.7.2 Sep 24, 2024: Cannabix Technologies and Omega Laboratories Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference
10.7.3 Sep 05, 2024: Positive Results of SB623 for Traumatic Brain Injury, Including Sustained Motor Function Improvement up to 48 weeks, published in Neurology
10.7.4 Jun 10, 2024: Netramark Announces Collaboration Agreement with NIMH to Analyze Clinical Trial Data on the Use of Ketamine in Psychiatric Disorders

11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Distribution Share Analysis
11.1.7 Benchmarking
11.2 the analyst Consulting
11.3 Contact the Publisher
11.4 Disclaimer

Table 1: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 2: Drug Delivery Devices Market, Canada, Category Contribution by Revenue ($m), 2023
Table 3: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 4: Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033
Table 5: Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033
Table 6: Drug Delivery Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2023
Table 7: Central Venous Catheters Market, Canada, Segment Contribution (%), 2023
Table 8: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 9: Central Venous Catheters Market, Canada, Volume (Units), 2018-2033
Table 10: Central Venous Catheters Market, Canada, Average Price ($), 2018-2033
Table 11: Central Venous Catheters Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023
Table 12: Central Venous Catheters Market, Canada, Company Share by Revenue ($m), USD Constant, 2023
Table 13: Implantable Ports Market, Canada, Segment Contribution (%), 2023
Table 14: Implantable Ports Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 15: Implantable Ports Market, Canada, Volume (Units), 2018-2033
Table 16: Implantable Ports Market, Canada, Average Price ($), 2018-2033
Table 17: Implantable Ports Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023
Table 18: Implantable Ports Market, Canada, Company Share by Revenue ($m), USD Constant, 2023
Table 19: Infusion Systems Market, Canada, Segment Contribution (%), 2023
Table 20: Infusion Systems Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 21: Infusion Pump Disposables Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 22: Infusion Pumps Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 23: Infusion Systems Market, Canada, Volume (Units), 2018-2033
Table 24: Infusion Pump Disposables Market, Canada, Volume (Units), 2018-2033
Table 25: Infusion Pumps Market, Canada, Volume (Units), 2018-2033
Table 26: Infusion Systems Market, Canada, Average Price ($), 2018-2033
Table 27: Infusion Systems Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023
Table 28: Infusion Systems Market, Canada, Company Share by Revenue ($m), USD Constant, 2023
Table 29: Drug Delivery Devices Market Pipeline Products
Table 30: Atai Life Sciences Acquires IntelGenx Technologies and IntelGenx (IGX Entities)
Table 31: NuGen Medical Devices Raises USD7.33 Million in Private Placement of 12% Secured Convertible Debentures
Table 32: Stockport Exploration (Sona Nanotech) Raises USD1.21 Million in Non-Brokered Private Placement of Shares
Table 33: Cypher Metaverse Raises Funds through Final Tranche Non-Brokered Private Placement of Shares
Table 34: Sona Nanotech Raises USD1.08 Million in Private Placement of Shares
Table 35: Jolt Health to Raise Upto USD0.36 Million in Non-Brokered Private Placement of Units
Table 36: Orion Biotechnology Canada Raises USD0.74 Million in Equity Financing
Table 37: InMed Pharma to Raise Up to USD1.03 Million in Equity Financing
Table 38: Total Number of Primary Research Participants, Drug Delivery Devices Market, by Country

Figure 1: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 2: Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2023
Figure 3: Drug Delivery Devices Market, Canada, Category Contribution (%), 2023
Figure 4: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 5: Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033
Figure 6: Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033
Figure 7: Drug Delivery Devices Market, Canada, Company Share (%) 2023
Figure 8: Central Venous Catheters Market, Canada, Revenue Mix ($m), 2023
Figure 9: Central Venous Catheters Market, Canada, Segment Contribution (%), 2023
Figure 10: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 11: Central Venous Catheters Market, Canada, Volume (Units), 2018-2033
Figure 12: Central Venous Catheters Market, Canada, Company Share (%) 2023
Figure 13: Implantable Ports Market, Canada, Revenue Mix ($m), 2023
Figure 14: Implantable Ports Market, Canada, Segment Contribution (%), 2023
Figure 15: Implantable Ports Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 16: Implantable Ports Market, Canada, Volume (Units), 2018-2033
Figure 17: Implantable Ports Market, Canada, Company Share (%) 2023
Figure 18: Infusion Systems Market, Canada, Revenue Mix ($m), 2023
Figure 19: Infusion Systems Market, Canada, Segment Contribution (%), 2023
Figure 20: Infusion Systems Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 21: Infusion Pump Disposables Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 22: Infusion Pumps Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 23: Infusion Systems Market, Canada, Volume (Units), 2018-2033
Figure 24: Infusion Pump Disposables Market, Canada, Volume (Units), 2018-2033
Figure 25: Infusion Pumps Market, Canada, Volume (Units), 2018-2033
Figure 26: Infusion Systems Market, Canada, Company Share (%) 2023